Related Experiment Video
Updated: Dec 14, 2025
06:29
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
31.0K
Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features
Abraham Z Cheloff1, David J Kuter1, Hanny Al-Samkari1
1Division of Hematology Massachusetts General Hospital Harvard Medical School Boston MA USA.
Research and Practice in Thrombosis and Haemostasis
|July 21, 2020
Summary
Complement levels are lower in immune thrombocytopenia (ITP) patients, particularly those with severe disease. This finding may guide future complement-targeted therapies for ITP.
Area of Science:
- Immunology
- Hematology
Background:
- Immune thrombocytopenia (ITP) involves platelet destruction, potentially mediated by the complement system.
- Serum complement levels in ITP patients remain incompletely characterized.
Purpose of the Study:
- To characterize complement component levels (C3, C4, CH50) in immune thrombocytopenia (ITP) patients.
- To compare complement levels between ITP patients and healthy individuals.
- To investigate the association between complement levels, disease severity, and treatment response in ITP.
Main Methods:
- Retrospective analysis of complement testing data from 108 ITP patients and 120 healthy controls.
- Comparison of mean complement levels between ITP patients and controls.
- Subgroup analyses within the ITP cohort and regression analyses to assess correlations with disease severity and treatment outcomes.
Main Results:
- Mean C3, C4, and CH50 levels were significantly lower in ITP patients compared to healthy subjects.
- Approximately 32% of ITP patients exhibited substantial reductions in one or more complement assays.
- Lower C4 and CH50 levels were associated with patients requiring treatment, while lower C4 predicted more severe ITP.
- Reduced complement levels did not predict treatment response to standard ITP therapies.
Conclusions:
- A significant proportion of ITP patients display reduced complement levels, correlating with disease severity.
- Further research is warranted to determine if hypocomplementemia predicts response to novel complement-directed therapies in ITP.
Related Concept Videos
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
188
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
188
01:27Complement System
8.3K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
8.3K
01:25Endocarditis II: Clinical Features of Infective Endocarditis
247
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
247
01:24Disorders of Hemostasis
1.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.7K
01:24Chronic Kidney Disease II: Clinical Manifestations
434
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
434
01:24Serum Studies: Renal Function Tests
263
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
263